Search Results 101-110 of 3221 for Solid
... Solid Tumors, Urothelial Carcinoma, Gastric cancer, Gastro-esophageal cancer, and Non-small cell lung cancer. Participation eligibility. Participant ...
Clinical Trials · A Dose Escalation Study of HFB301001 in Adult Patients with Advanced Solid Tumors · More about research at Mayo Clinic · Mayo Clinic Footer.
diff infection (CDI) in solid organ transplant (SOT) recipients in a randomized, controlled clinical trial. Participation eligibility. Participant ...
Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery ... solid tumors or ...
If the cyst has solid components, it may be benign or malignant and should have further evaluation. Often this is done with repeat imaging to see if the ...
... solid tumors in phase 1. Primary objective of Phase 1b is to assess overall response rate (ORR) determined by Investigator per RECIST v1.1 for patients in ...
Veliparib and Topotecan Hydrochloride in Treating Patients with Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer. Print ...
About this study. This phase I trial studies the side effects and the best dose of pazopanib hydrochloride in treating patients with solid tumors that has ...
... solid tumors harboring an NRG1 fusion. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
This phase I trial studies the side effects and the best dose of dabrafenib in treating patients with solid tumors and kidney or liver dysfunction.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.